Supernus Pharmaceuticals
SUPN
SUPN
233 hedge funds and large institutions have $1.15B invested in Supernus Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 66 increasing their positions, 98 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 98
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
39% less call options, than puts
Call options by funds: $1.87M | Put options by funds: $3.05M
Holders
233
Holding in Top 10
4
Calls
$1.87M
Puts
$3.05M
Top Buyers
| 1 | +$12.4M | |
| 2 | +$12.1M | |
| 3 | +$7.35M | |
| 4 |
Morgan Stanley
New York
|
+$4.47M |
| 5 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$4.01M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$10.2M | |
| 3 | -$9M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$6.38M |
| 5 |
NPIC
Neumeier Poma Investment Counsel
Carmel,
California
|
-$6.17M |